- Home
- FRO vs GRFS Comparison
FRO vs GRFS Comparison
Compare FRO & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FRO | GRFS |
|---|---|---|
| Founded | 1985 | 1940 |
| Country | Cyprus | Spain |
| Employees | N/A | 25247 |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 5.4B |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | FRO | GRFS |
|---|---|---|
| Price | $40.90 | $7.40 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 2 |
| Target Price | ★ $37.67 | $10.15 |
| AVG Volume (30 Days) | ★ 3.3M | 521.9K |
| Earning Date | 05-22-2026 | 07-28-2022 |
| Dividend Yield | ★ 4.85% | 1.80% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $4.49 |
| Revenue Next Year | N/A | $6.42 |
| P/E Ratio | $34.05 | ★ $18.67 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.25 | $7.26 |
| 52 Week High | $40.74 | $11.14 |
Technical Indicators
Market Signals| Indicator | FRO | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 69.80 | 39.71 |
| Support Level | $33.68 | $7.38 |
| Resistance Level | N/A | $8.88 |
| Average True Range (ATR) | 1.61 | 0.17 |
| MACD | 0.55 | 0.00 |
| Stochastic Oscillator | 99.16 | 20.90 |
Price Performance
Historical ComparisonAbout FRO Frontline Plc
Frontline PLC is an international shipping company engaged in the seaborne transportation of crude oil and oil products. Group operates through the tankers segment. The tankers segment includes crude oil tankers and product tankers. Its geographical area of operation includes Arabian Gulf, West African, the North Sea, and the Caribbean. Frontline earns revenue through voyage charters, time charters, and a finance lease. It is also involved in the charter, purchase, and sale of vessels.
About GRFS Grifols S.A.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.